. Crusting and weeping discharge indicating secondary infection of eczema helpful, though there is a lack of objective evidence to support the addition of an antiseptic. The use of topical mupirocin is unlikely to be helpful because of the cost, the impracticality of applying it all over the skin, and the emergence of mupirocin-resistant strains of staphylococci.
It has been suggested that patients with atopic eczema are allergic to staphylococci on their skin", and severaI 6 -11 though not all 12 studies have demonstrated high levels of anti-staphylococcal IgE in patients with atopic eczema. As with elevated levels of IgE directed against other antigens, the significance of such antibodies is far from clear 13 • 
Herpes simplex virus skin infections
Skin infections with the herpes simplex virus (HSV) are common in atopic eczema, though they are frequently unrecognized. In a prospective study of 179 children with atopic eczema who were observed for an average of 18 months, 10 children had initial infections with HSV and five patients had between them 11 episodes of recurrence of herpes simplex !'. The initial skin infections with HSV are commonly mild episodes, causing little systemic upset, and being characterized by a small number of vesicles with a central depression described as umbilicated vesicles ( Figure 2 ). The clear fluid in these lesions quickly becomes pustular but the umbilicated appearance persists and is virtually diagnostic of an initial infection with HSV. In severe cases, these vesicles coalesce and leave a raw ulcerated area of skin. There may be fever and general malaise. Rarely this systemic illness may be severe, and deaths from eczema herpeticum can occur'", In the past most of these deaths were attributable to unrecognized secondary bacterial skin infection'? or an underlying immune deficiency state such as the Wiskott-Aldrich syndrome 17 • 18 • Of the 10 children in the series described above with initial infections, four were very ill with a persistently high fever despite intravenous antibiotics and rectal aspirin, and because of the severity of the illness they were given intravenous acyclovir for five days'", The response to intravenous acyclovir is swift, and it may be that 48 hours treatment would suffice. Oral acyclovir has also been used'", but if the patient is well enough for oral acyclovir then the drug is probably unnecessary for this normally self-limiting disorder.
Recurrent skin infections with HSV are common, and their appearance is quite characteristic consisting of a cluster of vesicles on a patch of erythematous skin, the vesicles being thin walled and quickly breaking after they have been scratched. These recurrences are benign, not associated with severe illness, and all that is required is topical antiseptics'", It used to be thought that topical steroids were an important predisposing cause of severe herpes simplex infections in atopic eczema, but this is now known to be untrue!". Children with life threatening initial infections with HSV should be investigated for an underlying immune deficiency state, and we have seen two patients with severe eczema herpeticum, one of whom died, in whom there was an underlying IgG2 defici ency 2o. 21. It is not known whether the susceptibility of patients with atopic eczema to severe HSV infections is due to an underlying immunological abnormality or is merely attributable to the abnormal skin. It has been claimed that viral infections in general are more common in children with atopic eczema 22 , and HSV is cited as an example of this, but this is almost certainly untrue. A recent study showed that infections with HSV are no more common in children with atopic eczema than in the general population'". In support of the notion that viral skin infections are common in atopic eczema, it is frequently stated that there is a strong association between viral warts and atopic eczema, but this claim is based on the flimsiest of evidence, an uncontrolled observational study of 40 patients with warts 24 • The frequently repeated textbook statement that molluscum contagiosum is particularly common in atopic eczema is in fact based upon a single case report 25 ! Prevention of atopic eczema Since 1936, when Grulee and Sanford reported that breast feeding protected against atopic eczema-", the notion that atopic disease can be prevented by breast feeding has been surrounded by confusion. Not one study of this subject is without serious defect, and those from the greatest enthusiasts for breast feeding are often the most riddled with flaws. Objections to previous studies include: Observer bias.
Doctors known to be protagonists of breast feeding decided whether infants had eczema or a 'skin rash' in the full knowledge of whether the baby was breast or bottle fed. Non-blind ascertainment of history.
Interviewers asking for feeding history are likely to be biased if they know of the child's outcome (i.e. atopic status). Knowledge of the outcome tends to create an association between exposure and outcome where none exists. Feeding histories must be taken by someone who knows nothing about the child, and should be taken before the outcome is known.
Reliance on prolonged maternal recall.
A history taken years after the feeding period is prone to error regarding both the duration and exclusivity of breast feeding. Prospective studies avoid this problem. Adequate exclusivity of breast feeding.
If breast feeding is protective it may be through exclusion of foreign proteins like egg or cow's milk, or protection may be due to protective substances in human milk. The consumption of other foods during breast feeding may interfere with the protective effect of breast feeding. Unless breast feeding has been exclusive for a period of time, it is difficult to test the preventive effect of breast feeding.
Definition ofatopic diseases.
The conditions being investigated must be carefully defined. There should be a close agreement between the observations of two observers and between the observations of the same observer at different times. Skin rashes, wheezing and sneezing all have numerous causes. Not all are atopic.
Sufficient duration ofbreast feeding.
Brief exposure to human milk may not be expected to provide longterm protection against subsequent atopic disease. If breast feeding is protective, then the longer the duration of breast feeding the greater would be the expected protection against atopic disease. Assessement of disease severity.
Misleading information based on the failure to differentiate between minor and major forms of disease. Studies compared the total incidence of diseases such as eczema or asthma in babies fed different ways, but parents fear severe cases. It would be unhelpful to find a technique that abolished hairy patches over the sacrum but failed to prevent spina bifida. The protective effect of breast feeding is unlikely to be allor-none, so that if there is a genuine protective effect there should be some dose-response relationship. The demonstration of a graded degree of outcome in response to varying duration of breast feeding would strengthen the inference that breast feeding prevented the outcome.
Controls are essential to exclude confounding variables such as family history of atopic disease, racial origin, social class, exposure to pets and so on. Atopic mothers may, for example, preferentially breast feed in the hope of preventing atopic disease. This tends to bias the results against a protective effect of breast feeding, because the breast fed infant would then be at greater genetic risk of developing atopy.
Adequate follow-up is essential. Breast feeding may simply delay the age of onset of disease. Thus a followup study lasting 12 months might show a protective effect, but a 24 month follow-up might show no protective effect. Delaying the age of onset might be beneficial or harmful.
Contrary to the notion that breast feeding is protective, it is increasingly being recognized that in certain women ingested food antigens can pass into the milk. Maternal avoidance of the food in question is followed by remission of atopic disease in the infant, and re-exposure followed by relapse-". It is probable, though unproven, that mothers susceptible to this problem are themselves atopic. Thus the very women who might most wish to prevent atopic disease in their offspring may be just the ones in whom breast feeding contributes to the production of atopic disease. Two recent studies from Scandinavia have served to further undermine any belief in the protective effect of breast feeding, exclusive or otherwise. In the first, from Finland, a prospective study showed a steadily increasing incidence of atopic disease the longer a mother exclusively breast fed her infant'". In the second, from Sweden, a prospective study of breast fed babies showed that those who had been exclusively breast fed in the first few days of life were far more likely to develop atopic disease than those who were given supplementary cow's milk feeds for the first few days of life and then breast fed 29 • The message for doctors and parents is clear. The idea that eczema or asthma can be prevented by breast feeding, whether or not accompanied by other forms of antigen avoidance such as the delayed introduction of solids, seriously lacks objective validation.
